Investigating the Effects of SOX9 on Intestinal Mitochondria
Carolina Digital Repository (University of North Carolina at Chapel Hill) · 23.08.2025
DOI: 10.17615/jkk0-1h64 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carolina Digital Repository (University of North Carolina at Chapel Hill), erschienen am 23.08.2025. Verfasst von Whitney L. M. DeLoach.
Abstract (Originalsprache)
Reduced or dysfunctional mitochondria in intestinal epithelial cells are linked to the pathogenesis of inflammatory bowel diseases (IBD). Our group found the crypt-enriched transcription factor SOX9 represses total and active mitochondria in cultured human intestinal stem cells (ISCs), potentially acting as an early contributor to IBD development; however, how SOX9 regulates mitochondria is not fully understood in human intestinal cells. Thus, the major objective of this project is to explore the role of SOX9 in regulating mitochondrial levels in primary human intestinal stem cells.
Schlagwörter
Zitieren
APA
DeLoach, W. L. M. (2025). Investigating the Effects of SOX9 on Intestinal Mitochondria. Carolina Digital Repository (University of North Carolina at Chapel Hill). https://doi.org/10.17615/jkk0-1h64
Vancouver
DeLoach WLM. Investigating the Effects of SOX9 on Intestinal Mitochondria. Carolina Digital Repository (University of North Carolina at Chapel Hill). 2025. doi:10.17615/jkk0-1h64
BibTeX
@article{DeLoach2025,
author = {DeLoach, Whitney L. M.},
title = {Investigating the Effects of SOX9 on Intestinal Mitochondria},
journal = {Carolina Digital Repository (University of North Carolina at Chapel Hill)},
year = {2025},
doi = {10.17615/jkk0-1h64}
}
EUVIMED